IGF-1R Inhibitor Ameliorates Neuroinflammation in an Alzheimer’s Disease Transgenic Mouse Model
Aging is a major risk factor for Alzheimer’s disease (AD). Insulin-like growth factor-1 receptor (IGF-1R) regulates general aging and lifespan. However, the contribution of IGF-1 to age-related AD pathology and progression is highly controversial. Based on our previous work, AβPP/PS1 double transgen...
Main Authors: | Mona Sohrabi, Angela M. Floden, Gunjan D. Manocha, Marilyn G. Klug, Colin K. Combs |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-07-01
|
Series: | Frontiers in Cellular Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fncel.2020.00200/full |
Similar Items
-
Dual inhibition of IGF-IR and ALK as an effective strategy to eradicate NPM-ALK+ T-cell lymphoma
by: Bhawana George, et al.
Published: (2019-07-01) -
Upregulation of Prickle2 Ameliorates Alzheimer’s Disease-Like Pathology in a Transgenic Mouse Model of Alzheimer’s Disease
by: Fengxian Sun, et al.
Published: (2020-09-01) -
Targeting neuroinflammation in Alzheimer’s disease
by: Bronzuoli MR, et al.
Published: (2016-11-01) -
Neuroinflammation in Alzheimer’s Disease
by: Isaac G. Onyango, et al.
Published: (2021-05-01) -
Function of the microglia in neuroinflammation of Alzheimer's disease:a brief review
by: WANG Yuan-zhuo, ZHENG Qing-yue, ZHANG Han-lin, QIU Wen-ying, WANG Tao, MA Chao
Published: (2022-08-01)